PsychedelicNewsBreaks

ThursdayAug 10, 2017 9:32 am

PsychedelicNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) CEO Discusses Company’s Progress in Interview

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, this morning announced that its chief executive officer, Chris Bunka, was featured in a recent interview on the Uptick Network Stock Day Radio Show. Bunka leveraged the platform to discuss Lexaria’s overall accomplishments in the past three months, as well as the company’s expectations for profitability moving forward. He notes that ongoing research and development programs could open both the NSAID and Nicotine markets to Lexaria, providing an opportunity to significantly increase corporate revenues and facilitate further expansion. “In the…

Continue Reading

WednesdayAug 02, 2017 3:23 pm

PsychedelicNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Spotlighted by Technical420

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, including cannabinoids, was recently spotlighted in an article on Technical420.com. The publication highlighted, in detail, several of the company’s key developments and growth catalysts. “During the last few months, Lexaria has improved its fundamental story through the following developments: 1) The company applied for a new patent from the U.S., 2) Lexaria has advanced its agreements and launched new businesses, 3) Expands its Reach into Asia, 4) Focused on R&D with major organizations, and 5) The company’s cash position has…

Continue Reading

FridayJul 28, 2017 12:12 pm

PsychedelicNewsBreaks – Algae Dynamics Corp. (ADYNF) Developing Potential Breakthrough Fortified Formulas to Boost Human Endocannabinoid System

As debates continue over the legalization of marijuana, many individuals who have never touched plant-derived cannabinoids (phytocannabinoids) do not realize that their bodies naturally produce endocannabinoids, which play an essential mediating role in various human physiologic systems. Recent studies have shown that the production of endocannabinoids is boosted by fatty acids, and Algae Dynamics (OTCQB: ADYNF) has begun developing fortified formulas of omega-3s and cannabis oil that could potentially boost the function of the human body’s endocannabinoid system. “The products under development by Algae Dynamics promise to pack a powerful therapeutic punch, combining the virtues of omega-3s and cannabinoids. Algae…

Continue Reading

TuesdayJul 18, 2017 12:19 pm

PsychedelicNewsBreaks – Algae Dynamics Corp. (ADYNF) Featured in Exclusive Audio Interview by PsychedelicNewsWire

Multifaceted financial news and publishing company PsychedelicNewsWire (“PNW”) this morning announced the online availability of an exclusive audio interview with Algae Dynamics Corp. (OTCQB: ADYNF). In the interview, Paul Ramsay, president and chairman of Algae Dynamics, provides insight into the company’s operational focus on the development of unique health products and pharmaceuticals utilizing cannabis, hemp and algae oils. “We're working with cannabis in isolation, but we are also formulating different combinations of algae mixed with cannabis oils. It's quite an interesting program and quite exciting given the health benefits,” Ramsay noted. “We're doing this because we have a lot of…

Continue Reading

MondayJul 17, 2017 2:55 pm

PsychedelicNewsBreaks – Algae Dynamics Corp. (ADYNF) is Revolutionizing Plant-Based Therapeutics for a Range of Ailments

Algae Dynamics Corp. (OTC: ADYNF) has developed a unique strategy of producing a variety of products that combine the health benefits of both algae and cannabis oils. The synergistic effects of the two plant-based remedies hold tremendous promise, and the ability to sell and cross market the products to health conscious consumers gives the company real competitive advantages. A recent PNW article highlights the company’s progress in this innovative endeavor and notes key partnerships established to achieve its corporate goals: “With an ongoing commitment to science, Algae Dynamics has engaged two Canadian universities to perform research and product development into…

Continue Reading

WednesdayJun 28, 2017 12:12 pm

PsychedelicNewsBreaks – Algae Dynamics Corp. (ADYNF) Targets Nutraceutical Market Leveraging Health and Efficacy Effects of Algae-Cannabis Oils

The nutraceutical industry boasts a diversified playing field, and Canada-based Algae Dynamics Corp. (OTCQB: ADYNF) is taking a unique approach to this burgeoning market, focusing on the development of proprietary research and products that combine the health benefits of botanical oils derived from cannabis and algae. “The original core of the company’s product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed…

Continue Reading

ThursdayMay 11, 2017 11:09 am

PsychedelicNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Pursues Continued Success in CBD Markets

Leveraging its achievements of amassing a 100,000+ user base, establishing a recognizable 18-year-old brand, and sharpening its focus on a market that exceeds two billion Chinese-speaking individuals, ChineseInvestors.com (OTCQB: CIIX) has reached a first-in-the-marketplace milestone by launching the world’s first and only Chinese language, cannabinoid-based therapeutic health products web store, http://www.ChineseCBDoil.com. After making a successful investment in the marijuana market, the company recently expanded into the retail and online sale of cannabidiol (CBD), which has become one of the fastest-growing market categories in the United States. “With an annual growth rate of nearly 60 percent, CBD oil has become one…

Continue Reading

ThursdayMay 11, 2017 11:07 am

PsychedelicNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Poised to Become Phytocannabinoid Pharmaceuticals Leader

At its recent 70th annual meeting, the American Epilepsy Society (AES) highlighted a study focusing on the potential of cannabidiol (CBD) to treat the frequency and severity of seizures in children who have drug-resistant epilepsies. India Globalization Capital (NYSE MKT: IGC), an innovator in developing cannabis-based combination therapies to treat pain and other conditions, is currently applying the revolutionary seizure-treating potential of CBD to another population: domestic pets, and the company is addressing the 5 percent of dogs and just over 2 percent of cats in the United States that experience seizures. “Cannabidiol is the most abundant non-psychoactive cannabinoid found…

Continue Reading